NASDAQ:IOSP

Innospec Competitors

$102.53
+0.50 (+0.49 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$101.76
Now: $102.53
$103.31
50-Day Range
$97.00
MA: $102.49
$105.95
52-Week Range
$61.48
Now: $102.53
$107.73
Volume3,998 shs
Average Volume95,140 shs
Market Capitalization$2.52 billion
P/E Ratio68.81
Dividend Yield1.01%
Beta1.34

Competitors

Innospec (NASDAQ:IOSP) Vs. SHW, ECL, IFF, CE, ALB, and RPM

Should you be buying IOSP stock or one of its competitors? Companies in the sub-industry of "specialty chemicals" are considered alternatives and competitors to Innospec, including The Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), Albemarle (ALB), and RPM International (RPM).

Innospec (NASDAQ:IOSP) and The Sherwin-Williams (NYSE:SHW) are both basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Institutional and Insider Ownership

92.9% of Innospec shares are held by institutional investors. Comparatively, 76.5% of The Sherwin-Williams shares are held by institutional investors. 1.4% of Innospec shares are held by company insiders. Comparatively, 0.6% of The Sherwin-Williams shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Volatility and Risk

Innospec has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, The Sherwin-Williams has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.

Profitability

This table compares Innospec and The Sherwin-Williams' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innospec2.92%9.14%6.01%
The Sherwin-Williams10.41%56.69%10.66%

Analyst Ratings

This is a summary of recent ratings and target prices for Innospec and The Sherwin-Williams, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innospec00103.00
The Sherwin-Williams131502.74

Innospec currently has a consensus target price of $110.00, indicating a potential upside of 7.29%. The Sherwin-Williams has a consensus target price of $285.3333, indicating a potential upside of 11.77%. Given The Sherwin-Williams' higher possible upside, analysts plainly believe The Sherwin-Williams is more favorable than Innospec.

Dividends

Innospec pays an annual dividend of $1.04 per share and has a dividend yield of 1.0%. The Sherwin-Williams pays an annual dividend of $2.20 per share and has a dividend yield of 0.9%. Innospec pays out 19.9% of its earnings in the form of a dividend. The Sherwin-Williams pays out 10.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Sherwin-Williams has increased its dividend for 42 consecutive years.

Valuation & Earnings

This table compares Innospec and The Sherwin-Williams' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.51 billion1.67$112.20 million$5.2219.64
The Sherwin-Williams$17.90 billion3.83$1.54 billion$21.1212.09

The Sherwin-Williams has higher revenue and earnings than Innospec. The Sherwin-Williams is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Summary

The Sherwin-Williams beats Innospec on 11 of the 17 factors compared between the two stocks.

Innospec (NASDAQ:IOSP) and Ecolab (NYSE:ECL) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Institutional and Insider Ownership

92.9% of Innospec shares are owned by institutional investors. Comparatively, 73.6% of Ecolab shares are owned by institutional investors. 1.4% of Innospec shares are owned by company insiders. Comparatively, 1.2% of Ecolab shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Innospec has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Ecolab has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Profitability

This table compares Innospec and Ecolab's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innospec2.92%9.14%6.01%
Ecolab-8.21%18.14%6.75%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Innospec and Ecolab, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innospec00103.00
Ecolab08702.47

Innospec currently has a consensus target price of $110.00, indicating a potential upside of 7.29%. Ecolab has a consensus target price of $216.2727, indicating a potential downside of 1.44%. Given Innospec's stronger consensus rating and higher possible upside, equities analysts plainly believe Innospec is more favorable than Ecolab.

Dividends

Innospec pays an annual dividend of $1.04 per share and has a dividend yield of 1.0%. Ecolab pays an annual dividend of $1.92 per share and has a dividend yield of 0.9%. Innospec pays out 19.9% of its earnings in the form of a dividend. Ecolab pays out 33.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ecolab has raised its dividend for 36 consecutive years. Innospec is clearly the better dividend stock, given its higher yield and lower payout ratio.

Valuation and Earnings

This table compares Innospec and Ecolab's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.51 billion1.67$112.20 million$5.2219.64
Ecolab$14.91 billion4.21$1.56 billion$5.8237.70

Ecolab has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than Ecolab, indicating that it is currently the more affordable of the two stocks.

Summary

Innospec beats Ecolab on 9 of the 17 factors compared between the two stocks.

Innospec (NASDAQ:IOSP) and International Flavors & Fragrances (NYSE:IFF) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Institutional and Insider Ownership

92.9% of Innospec shares are owned by institutional investors. Comparatively, 94.4% of International Flavors & Fragrances shares are owned by institutional investors. 1.4% of Innospec shares are owned by company insiders. Comparatively, 0.4% of International Flavors & Fragrances shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Innospec has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, International Flavors & Fragrances has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.

Profitability

This table compares Innospec and International Flavors & Fragrances' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innospec2.92%9.14%6.01%
International Flavors & Fragrances7.44%11.00%5.10%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Innospec and International Flavors & Fragrances, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innospec00103.00
International Flavors & Fragrances041102.73

Innospec currently has a consensus target price of $110.00, indicating a potential upside of 7.29%. International Flavors & Fragrances has a consensus target price of $144.4571, indicating a potential upside of 2.98%. Given Innospec's stronger consensus rating and higher possible upside, equities analysts plainly believe Innospec is more favorable than International Flavors & Fragrances.

Dividends

Innospec pays an annual dividend of $1.04 per share and has a dividend yield of 1.0%. International Flavors & Fragrances pays an annual dividend of $3.08 per share and has a dividend yield of 2.2%. Innospec pays out 19.9% of its earnings in the form of a dividend. International Flavors & Fragrances pays out 49.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. International Flavors & Fragrances has raised its dividend for 11 consecutive years. International Flavors & Fragrances is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation and Earnings

This table compares Innospec and International Flavors & Fragrances' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.51 billion1.67$112.20 million$5.2219.64
International Flavors & Fragrances$5.14 billion6.79$455.87 million$6.1722.74

International Flavors & Fragrances has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than International Flavors & Fragrances, indicating that it is currently the more affordable of the two stocks.

Summary

International Flavors & Fragrances beats Innospec on 10 of the 17 factors compared between the two stocks.

Innospec (NASDAQ:IOSP) and Celanese (NYSE:CE) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Institutional and Insider Ownership

92.9% of Innospec shares are owned by institutional investors. Comparatively, 97.5% of Celanese shares are owned by institutional investors. 1.4% of Innospec shares are owned by company insiders. Comparatively, 0.7% of Celanese shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Innospec has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Celanese has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500.

Profitability

This table compares Innospec and Celanese's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innospec2.92%9.14%6.01%
Celanese10.46%31.41%9.42%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Innospec and Celanese, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innospec00103.00
Celanese171202.55

Innospec currently has a consensus target price of $110.00, indicating a potential upside of 7.29%. Celanese has a consensus target price of $129.1111, indicating a potential downside of 15.24%. Given Innospec's stronger consensus rating and higher possible upside, equities analysts plainly believe Innospec is more favorable than Celanese.

Dividends

Innospec pays an annual dividend of $1.04 per share and has a dividend yield of 1.0%. Celanese pays an annual dividend of $2.72 per share and has a dividend yield of 1.8%. Innospec pays out 19.9% of its earnings in the form of a dividend. Celanese pays out 28.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Celanese has raised its dividend for 1 consecutive years. Celanese is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation and Earnings

This table compares Innospec and Celanese's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.51 billion1.67$112.20 million$5.2219.64
Celanese$6.30 billion2.76$852 million$9.5315.98

Celanese has higher revenue and earnings than Innospec. Celanese is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

Summary

Celanese beats Innospec on 11 of the 17 factors compared between the two stocks.

Innospec (NASDAQ:IOSP) and Albemarle (NYSE:ALB) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Institutional and Insider Ownership

92.9% of Innospec shares are owned by institutional investors. Comparatively, 86.4% of Albemarle shares are owned by institutional investors. 1.4% of Innospec shares are owned by company insiders. Comparatively, 1.1% of Albemarle shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Innospec has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500.

Profitability

This table compares Innospec and Albemarle's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innospec2.92%9.14%6.01%
Albemarle11.77%11.96%4.97%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Innospec and Albemarle, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innospec00103.00
Albemarle57902.19

Innospec currently has a consensus target price of $110.00, indicating a potential upside of 7.29%. Albemarle has a consensus target price of $124.3636, indicating a potential downside of 15.51%. Given Innospec's stronger consensus rating and higher possible upside, equities analysts plainly believe Innospec is more favorable than Albemarle.

Dividends

Innospec pays an annual dividend of $1.04 per share and has a dividend yield of 1.0%. Albemarle pays an annual dividend of $1.56 per share and has a dividend yield of 1.1%. Innospec pays out 19.9% of its earnings in the form of a dividend. Albemarle pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has raised its dividend for 27 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation and Earnings

This table compares Innospec and Albemarle's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.51 billion1.67$112.20 million$5.2219.64
Albemarle$3.59 billion4.79$533.23 million$6.0424.37

Albemarle has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than Albemarle, indicating that it is currently the more affordable of the two stocks.

Summary

Albemarle beats Innospec on 10 of the 17 factors compared between the two stocks.

Innospec (NASDAQ:IOSP) and RPM International (NYSE:RPM) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Innospec and RPM International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innospec00103.00
RPM International04502.56

Innospec currently has a consensus target price of $110.00, indicating a potential upside of 7.29%. RPM International has a consensus target price of $95.8750, indicating a potential upside of 4.48%. Given Innospec's stronger consensus rating and higher possible upside, equities analysts plainly believe Innospec is more favorable than RPM International.

Risk & Volatility

Innospec has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, RPM International has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Dividends

Innospec pays an annual dividend of $1.04 per share and has a dividend yield of 1.0%. RPM International pays an annual dividend of $1.52 per share and has a dividend yield of 1.7%. Innospec pays out 19.9% of its earnings in the form of a dividend. RPM International pays out 49.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. RPM International has raised its dividend for 19 consecutive years. RPM International is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Profitability

This table compares Innospec and RPM International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innospec2.92%9.14%6.01%
RPM International7.50%35.72%8.85%

Institutional and Insider Ownership

92.9% of Innospec shares are owned by institutional investors. Comparatively, 74.7% of RPM International shares are owned by institutional investors. 1.4% of Innospec shares are owned by company insiders. Comparatively, 1.6% of RPM International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Innospec and RPM International's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.51 billion1.67$112.20 million$5.2219.64
RPM International$5.51 billion2.17$304.39 million$3.0729.89

RPM International has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than RPM International, indicating that it is currently the more affordable of the two stocks.

Summary

RPM International beats Innospec on 10 of the 17 factors compared between the two stocks.


Innospec Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
The Sherwin-Williams logo
SHW
The Sherwin-Williams
2.7$255.29+0.7%$68.62 billion$17.90 billion12.60
Ecolab logo
ECL
Ecolab
2.2$219.44+1.6%$62.78 billion$14.91 billion-59.47
International Flavors & Fragrances logo
IFF
International Flavors & Fragrances
2.5$140.28+1.4%$34.91 billion$5.14 billion42.00
Celanese logo
CE
Celanese
2.2$152.33+1.5%$17.39 billion$6.30 billion31.54
Albemarle logo
ALB
Albemarle
2.1$147.20+0.1%$17.19 billion$3.59 billion41.12
RPM International logo
RPM
RPM International
2.3$91.76+0.0%$11.94 billion$5.51 billion27.81Earnings Announcement
Dividend Announcement
Analyst Report
Analyst Revision
Ashland Global logo
ASH
Ashland Global
1.8$88.80+0.9%$5.39 billion$2.33 billion-10.57
Quaker Chemical logo
KWR
Quaker Chemical
2.0$244.47+1.8%$4.36 billion$1.13 billion679.10
NewMarket logo
NEU
NewMarket
1.0$386.24+0.8%$4.22 billion$2.19 billion16.81
W. R. Grace & Co. logo
GRA
W. R. Grace & Co.
2.0$62.70+0.9%$4.15 billion$1.96 billion298.57
Balchem logo
BCPC
Balchem
1.8$121.27+0.6%$3.93 billion$643.71 million47.56
Sensient Technologies logo
SXT
Sensient Technologies
1.8$79.44+1.3%$3.36 billion$1.32 billion49.96
H.B. Fuller logo
FUL
H.B. Fuller
2.1$64.06+0.9%$3.35 billion$2.90 billion29.12Dividend Increase
Stepan logo
SCL
Stepan
2.2$127.72+1.3%$2.87 billion$1.86 billion25.04
Minerals Technologies logo
MTX
Minerals Technologies
1.8$76.69+1.6%$2.59 billion$1.79 billion23.97
Ferro logo
FOE
Ferro
1.1$17.00+0.7%$1.41 billion$1.02 billion-283.29
Kraton logo
KRA
Kraton
1.2$36.84+4.2%$1.17 billion$1.80 billion-5.17
FutureFuel logo
FF
FutureFuel
1.3$13.82+0.4%$604.53 million$205.23 million5.32
Landec logo
LNDC
Landec
2.0$9.91+1.1%$290.59 million$590.37 million-5.70Earnings Announcement
Analyst Report
High Trading Volume
Analyst Revision
Flotek Industries logo
FTK
Flotek Industries
0.6$1.56+0.6%$113.18 million$119.35 million-0.61
Advanced Emissions Solutions logo
ADES
Advanced Emissions Solutions
0.9$5.22+2.7%$96.67 million$70.09 million-7.91
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.